Arkolith/Insider Trading/CERE/Form 4

Giordano Douglas E.

DirectorCerevel Therapeutics Holdings, Inc. (CERE) · full profile →Form 4 · filed Aug 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2024Disposed to issuer(D)3K——10K
Aug 1, 2024Disposed to issuer(D)10K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2024Disposed to issuer(D)95K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-090853) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML